IN Brief:
- Hyderabad Airport has opened Cargo Terminal 2 at Rajiv Gandhi International Airport.
- The terminal includes a fully temperature-controlled pharma zone for pharmaceutical and perishable cargo.
- The project strengthens Hyderabad’s role as a major air cargo and life sciences logistics gateway.
GMR Hyderabad International Airport has opened Cargo Terminal 2 at Rajiv Gandhi International Airport, adding new infrastructure for pharmaceutical, perishable, express, general, import, and export cargo flows.
The terminal has been designed with dedicated import and export zones, domestic inbound and outbound areas, spacious processing zones, multi-level storage racks, and expanded shipment handling space. A fully temperature-controlled pharma zone forms the centrepiece of the facility, supporting pharmaceutical and perishable cargo with advanced temperature monitoring and cold-chain control.
Dedicated road access, reliable power, and streamlined cargo flows are intended to reduce dwell time, speed regulatory clearances, and support uninterrupted handling. The building also incorporates energy-efficient lighting, optimised HVAC systems, resource-efficient materials, and a multi-level fire detection and alarm system.
Hyderabad’s air cargo role is closely tied to the city’s life sciences cluster. The region is one of India’s most important pharmaceutical manufacturing bases, with strong production activity across active pharmaceutical ingredients, finished medicines, vaccines, and related healthcare products. Airport-linked cold-chain infrastructure therefore forms part of the industrial system connecting manufacturing output with regulated export markets.
Pharmaceutical logistics depends on control at every handover. Products can move from production sites to road transport, airport cargo terminals, airline handling, international gateways, and onward distribution networks. Each transition creates exposure to temperature excursion, documentation delay, shipment dwell, or handling error. Additional terminal capacity with dedicated cold-chain capability helps reduce the operational risk created by congestion and mixed cargo environments.
Healthcare supply chains are being rebuilt around more specialised logistics nodes. General cargo warehouses and ad hoc temperature control are no longer sufficient for high-value medicines, biologics, vaccines, diagnostics, and other sensitive healthcare flows. Manufacturers need controlled rooms, validated processes, shipment visibility, trained handling teams, and faster transfer between production, air freight, and destination-country distribution.
Hyderabad’s logistics base has been strengthening around that requirement. Kuehne+Nagel’s Hyderabad pharma cold-chain facility added specialist capacity close to India’s life sciences manufacturing clusters, while GEODIS is opening a GDP-compliant pharmaceutical warehouse near Manchester Airport to support UK healthcare flows.
Across those projects, the direction is towards a more distributed healthcare logistics model. Instead of relying only on large global hub airports, providers are placing controlled handling capacity nearer to production and regional demand centres. Proximity can cut first-mile exposure, simplify coordination with forwarders, and improve response time when shipments need intervention before export.
Hyderabad Cargo Terminal 2 also supports perishables, which share some of the same operational requirements as healthcare cargo: fast transfer, temperature management, clear documentation, and reduced dwell time. As food exports, high-value agricultural products, and healthcare shipments compete for controlled capacity, airport cargo terminals are having to support multiple temperature-sensitive sectors without treating cold chain as a bolt-on function.
The new terminal gives Hyderabad additional scale and process control in a market where air cargo performance is increasingly judged by reliability, not only capacity. For pharmaceutical exports especially, the strongest logistics infrastructure is the infrastructure that keeps products stable, documented, and moving.
